Literature DB >> 19057629

Preliminary results of a randomized, equivalence trial of fluoroscopic caudal epidural injections in managing chronic low back pain: Part 4--Spinal stenosis.

Laxmaiah Manchikanti1, Kimberly A Cash, Carla D McManus, Vidyasagar Pampati, Salahadin Abdi.   

Abstract

BACKGROUND: Spinal stenosis is one of the 3 most common diagnoses of low back and leg symptoms which also include disc herniation and degenerative spondylolisthesis. Spinal stenosis is a narrowing of the spinal canal with encroachment on the neural structures by surrounding the bone and soft tissue. In the United States, one of the most commonly performed interventions for managing chronic low back pain are epidural injections, including their use for spinal stenosis. However, there have not been any randomized trials and evidence is limited with regards to the effectiveness of epidural injections in managing chronic function-limiting low back and lower extremity pain secondary to lumbar spinal stenosis. STUDY
DESIGN: A randomized, double-blind, equivalence trial.
SETTING: An interventional pain management practice, a specialty referral center, a private practice setting in the United States.
OBJECTIVES: To evaluate the effectiveness of caudal epidural injections with or without steroids in providing effective and long-lasting pain relief in the management of chronic low back pain in spinal stenosis and to evaluate the differences between local anesthetic with or without steroids.
METHODS: Patients were randomly assigned to one of 2 groups, with Group I patients receiving caudal epidural injections of local anesthetic (lidocaine 0.5%), whereas Group II patients received caudal epidural injections with 0.5% lidocaine 9 mL mixed with 1 mL of steroid. Randomization is being performed by computer-generated random allocation sequence by simple randomization. OUTCOMES ASSESSMENT: Multiple outcome measures were utilized which included the Numeric Rating Scale (NRS), the Oswestry Disability Index 2.0 (ODI), employment status, and opioid intake with assessment at 3 months, 6 months, and 12 months post-treatment. Significant pain relief was defined as 50% or more, whereas significant improvement in disability score was defined as reduction of 40% or more.
RESULTS: Significant pain relief (> or =50%) was demonstrated in 55% to 65% of the patients and functional status improvement with 40% reduction in ODI scores in 55% to 80% of the patients. The overall average procedures per year were 3.4 +/- 1.27 in Group I and 2.6 +/- 1.35 in Group II with an average total relief per year of 30.3 +/- 19.49 weeks in Group I and 23.1 +/- 21.36 weeks in Group II over a period of 52 weeks. LIMITATIONS: The results of this study are limited by the lack of a placebo group and a preliminary report of 20 patients in each group, even though sample was justified.
CONCLUSION: Caudal epidural injections with or without steroids may be effective in patients with chronic function-limiting low back and lower extremity pain with spinal stenosis in approximately 60% of the patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057629

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  21 in total

Review 1.  Epidural steroid injections in the management of low-back pain with radiculopathy: an update of their efficacy and safety.

Authors:  Michel Benoist; Philippe Boulu; Gilles Hayem
Journal:  Eur Spine J       Date:  2011-09-16       Impact factor: 3.134

Review 2.  Lumbar spinal stenosis.

Authors:  Stephane Genevay; Steven J Atlas
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-04       Impact factor: 4.098

Review 3.  Transforaminal injection of corticosteroids for lumbar radiculopathy: systematic review and meta-analysis.

Authors:  Nasir A Quraishi
Journal:  Eur Spine J       Date:  2011-09-04       Impact factor: 3.134

4.  Evaluation of lumbar facet joint nerve blocks in managing chronic low back pain: a randomized, double-blind, controlled trial with a 2-year follow-up.

Authors:  Laxmaiah Manchikanti; Vijay Singh; Frank J E Falco; Kimberly A Cash; Vidyasagar Pampati
Journal:  Int J Med Sci       Date:  2010-05-28       Impact factor: 3.738

5.  MR epidurography: distribution of injectate at caudal epidural injection.

Authors:  Darra T Murphy; Eoin C Kavanagh; Ashley Poynton; Vikki O Chan; Michael R Moynagh; Stephen Eustace
Journal:  Skeletal Radiol       Date:  2014-08-02       Impact factor: 2.199

6.  Lumbar facet joint injection: feasibility as an alternative method in high-risk patients.

Authors:  Su Yeon Hwang; Joon Woo Lee; Geun Young Lee; Heung Sik Kang
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

7.  Fluoroscopically guided caudal epidural steroid injection for management of degenerative lumbar spinal stenosis: short-term and long-term results.

Authors:  Joon Woo Lee; Jae Sung Myung; Kun Woo Park; Jin S Yeom; Ki-Jeong Kim; Hyun-Jib Kim; Heung Sik Kang
Journal:  Skeletal Radiol       Date:  2009-12-22       Impact factor: 2.199

8.  Epidural corticosteroid injections for lumbosacral radicular pain.

Authors:  Crystian B Oliveira; Christopher G Maher; Manuela L Ferreira; Mark J Hancock; Vinicius Cunha Oliveira; Andrew J McLachlan; Bart W Koes; Paulo H Ferreira; Steven P Cohen; Rafael Zambelli Pinto
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

9.  Fluoroscopic cervical epidural injections in chronic axial or disc-related neck pain without disc herniation, facet joint pain, or radiculitis.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Vidyasagar Pampati; Yogesh Malla
Journal:  J Pain Res       Date:  2012-07-04       Impact factor: 3.133

10.  Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults.

Authors:  Janna L Friedly; Brian W Bresnahan; Bryan Comstock; Judith A Turner; Richard A Deyo; Sean D Sullivan; Patrick Heagerty; Zoya Bauer; Srdjan S Nedeljkovic; Andrew L Avins; David Nerenz; Jeffrey G Jarvik
Journal:  BMC Musculoskelet Disord       Date:  2012-03-29       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.